Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paul M. Copeland

Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients

Journal of Clinical Psychopharmacology

English

Waist Circumference Is the Best Anthropometric Predictor for Insulin Resistance in Nondiabetic Patients With Schizophrenia Treated With Clozapine but Not Olanzapine

Journal of Psychiatric Practice

Psychiatry

Mental Health

2009

English

Related publications

Double-Blind, Randomized Trial Comparing Efficacy and Safety of Continuing Olanzapine Versus Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia or Schizoaffective Disorder

Therapeutics and Clinical Risk Management

2008

English

Cost/Effectiveness of Aripiprazole vs. Olanzapine in the Long-Term Treatment of Schizophrenia

Srpski Arhiv Za Celokupno Lekarstvo

Medicine

2019

English

One-Year Follow-Up on Liraglutide Treatment for Prediabetes and Overweight/Obesity in Clozapine- Or Olanzapine-Treated Patients

Acta Psychiatrica Scandinavica

Psychiatry

Mental Health

2018

English

Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia

Journal of Clinical Psychiatry

English

Predictive Factors of Overall Functioning Improvement in Patients With Chronic Schizophrenia and Schizoaffective Disorder Treated With Paliperidone Palmitate and Aripiprazole Monohydrate

Human Psychopharmacology

English

Predictive Factors of Overall Functioning Improvement in Patients With Chronic Schizophrenia and Schizoaffective Disorder Treated With Paliperidone Palmitate and Aripiprazole Monohydrate

Human Psychopharmacology

English

Correction To: Effectiveness of Aripiprazole Once-Monthly in Schizophrenia Patients Pretreated With Oral Aripiprazole: A 6-Month, Real-Life Non-Interventional Study

English

Post-Injection Delirium/Sedation Syndrome in Patients With Schizophrenia Treated With Olanzapine Long-Acting Injection, I: Analysis of Cases

English

The Association of Genetic Polymorphisms in CYP1A2, UGT1A4, and ABCB1 With Autonomic Nervous System Dysfunction in Schizophrenia Patients Treated With Olanzapine

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paul M. Copeland

Aripiprazole Added to Overweight and Obese Olanzapine-Treated Schizophrenia Patients

Waist Circumference Is the Best Anthropometric Predictor for Insulin Resistance in Nondiabetic Patients With Schizophrenia Treated With Clozapine but Not Olanzapine

Related publications

Double-Blind, Randomized Trial Comparing Efficacy and Safety of Continuing Olanzapine Versus Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia or Schizoaffective Disorder

Cost/Effectiveness of Aripiprazole vs. Olanzapine in the Long-Term Treatment of Schizophrenia

One-Year Follow-Up on Liraglutide Treatment for Prediabetes and Overweight/Obesity in Clozapine- Or Olanzapine-Treated Patients

Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia

Predictive Factors of Overall Functioning Improvement in Patients With Chronic Schizophrenia and Schizoaffective Disorder Treated With Paliperidone Palmitate and Aripiprazole Monohydrate

Predictive Factors of Overall Functioning Improvement in Patients With Chronic Schizophrenia and Schizoaffective Disorder Treated With Paliperidone Palmitate and Aripiprazole Monohydrate

Correction To: Effectiveness of Aripiprazole Once-Monthly in Schizophrenia Patients Pretreated With Oral Aripiprazole: A 6-Month, Real-Life Non-Interventional Study

Post-Injection Delirium/Sedation Syndrome in Patients With Schizophrenia Treated With Olanzapine Long-Acting Injection, I: Analysis of Cases

The Association of Genetic Polymorphisms in CYP1A2, UGT1A4, and ABCB1 With Autonomic Nervous System Dysfunction in Schizophrenia Patients Treated With Olanzapine